Soichiro Yoshida

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Magnetic Resonance

Lower Urinary Tract Symptoms

Diffusion Weighted

Placebo Controlled

Top Venues

IJU case reports

International journal of urology : official journal of the Japanese Urological Association

European radiology

This page only lists publications with an associated author ORCID identifier.

Publications

Motohiro Fujiwara, Wataru Shimada, Minato Yokoyama, Anri Koyanagi, Hiroshi Shintaku, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii
Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma. IJU case reports 7 (4) (2024)
Motohiro Fujiwara, Wataru Shimada, Minato Yokoyama, Anri Koyanagi, Hiroshi Shintaku, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii
Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma. IJU case reports 7 (4) (2024)
Hiroki Tanaka, Soichiro Yoshida, Satoru Aoyama, Sadakatsu Ikeda, Junko Kunieda, Kenichi Ohashi, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii
A case of double-negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab. IJU case reports 7 (5) (2024)
Yuki Nakamura, Yudai Ishikawa, Masaki Kobayashi, Motohiro Fujiwara, Bo Fan, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii
Location-specific diagnostic efficiency of photodynamic diagnosis-guided biopsy in bladder mapping biopsies. International journal of urology : official journal of the Japanese Urological Association (2024)
Madoka Kataoka, Minato Yokoyama, Yuma Waseda, Masaya Ito, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Hitoshi Masuda, Yasuhisa Fujii
Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Lower urinary tract symptoms (2023)
Bo Fan, Minato Yokoyama, Masaki Kobayashi, Yuki Nakamura, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii
Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years. International journal of urology : official journal of the Japanese Urological Association (2023)
Koichiro Kimura, Soichiro Yoshida, Junichi Tsuchiya, Yoshio Kitazume, Yuma Waseda, Hajime Tanaka, Minato Yokoyama, Kazuma Toda, Ryoichi Yoshimura, Ito Masaya, Fumitaka Koga, Ukihide Tateishi, Yasuhisa Fujii
Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer. European radiology (2023)
Soichiro Yoshida, Taro Takahara, Yuki Arita, Masaya Ito, Sara Hayakawa, Tomohiko Oguchi, Yoshinobu Komai, Noboru Numao, Takeshi Yuasa, Masaharu Inoue, Hiroki Ushijima, Shigehiro Kudo, Yasumasa Shimano, Yuki Nakamura, Yusuke Uchida, Sho Uehara, Hajime Tanaka, Hiroshi Yaegashi, Kouji Izumi, Minato Yokoyama, Yoh Matsuoka, Yasuo Yoshioka, Koji Konishi, Katsuyuki Nakanishi, Akira Nagahara, Akihiro Hirakawa, Ryuji Koike, Fumitaka Koga, Kazuo Nishimura, Atsushi Mizokami, Junji Yonese, Yukio Kageyama, Ryoichi Yoshimura, Yasuhisa Fujii
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL). BMC urology 23 (1) (2023)
Soichiro Yoshida, Taro Takahara, Yuki Arita, Masaya Ito, Sara Hayakawa, Tomohiko Oguchi, Yoshinobu Komai, Noboru Numao, Takeshi Yuasa, Masaharu Inoue, Hiroki Ushijima, Shigehiro Kudo, Yasumasa Shimano, Yuki Nakamura, Yusuke Uchida, Sho Uehara, Hajime Tanaka, Hiroshi Yaegashi, Kouji Izumi, Minato Yokoyama, Yoh Matsuoka, Yasuo Yoshioka, Koji Konishi, Katsuyuki Nakanishi, Akira Nagahara, Akihiro Hirakawa, Ryuji Koike, Fumitaka Koga, Kazuo Nishimura, Atsushi Mizokami, Junji Yonese, Yukio Kageyama, Ryoichi Yoshimura, Yasuhisa Fujii
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL). BMC urology 23 (1) (2023)
Soichiro Yoshida, Taro Takahara, Yuki Arita, Masaya Ito, Sara Hayakawa, Tomohiko Oguchi, Yoshinobu Komai, Noboru Numao, Takeshi Yuasa, Masaharu Inoue, Hiroki Ushijima, Shigehiro Kudo, Yasumasa Shimano, Yuki Nakamura, Yusuke Uchida, Sho Uehara, Hajime Tanaka, Hiroshi Yaegashi, Kouji Izumi, Minato Yokoyama, Yoh Matsuoka, Yasuo Yoshioka, Koji Konishi, Katsuyuki Nakanishi, Akira Nagahara, Akihiro Hirakawa, Ryuji Koike, Fumitaka Koga, Kazuo Nishimura, Atsushi Mizokami, Junji Yonese, Yukio Kageyama, Ryoichi Yoshimura, Yasuhisa Fujii
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL). BMC urology 23 (1) (2023)
Takahiko Soma, Soichiro Yoshida, Ryo Wakejima, Towako Taguchi, Shohei Fukuda, Hajime Tanaka, Minato Yokoyama, Kenichi Ohashi, Kenichi Okubo, Yasuhisa Fujii
A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy. IJU case reports 6 (4) (2023)
Yoshitomo Yamaguchi, Minato Yokoyama, Akira Takemoto, Yuki Nakamura, Shohei Fukuda, Sho Uehara, Hajime Tanaka, Soichiro Yoshida, Yoh Matsuoka, Yasuhisa Fujii
Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma. IJU case reports 5 (6) (2022)
Soichiro Yoshida, Taro Takahara, Yuki Arita, Kazuma Toda, Koichiro Kimura, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Yasuhisa Fujii
Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers 14 (3) (2022)
Yusuke Uchida, Soichiro Yoshida, Yuki Arita, Hiroki Shimoda, Koichiro Kimura, Ichiro Yamada, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Masahiro Jinzaki, Yasuhisa Fujii
Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma. Diagnostics (Basel, Switzerland) 12 (4) (2022)
Yuki Nakamura, Hiroshi Fukushima, Kasumi Kaneko Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii
Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. International journal of urology : official journal of the Japanese Urological Association (2022)
Shimpei Yamamoto, Soichiro Yoshida, Chikako Ishii, Taro Takahara, Yuki Arita, Hiroshi Fukushima, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Yasuhisa Fujii
Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. Journal of magnetic resonance imaging : JMRI 54 (2) (2021)
Soichiro Yoshida, Yasuhisa Fujii
Editorial Comment from Dr Yoshida and Dr Fujii to Role of Vesical Imaging-Reporting and Data System in predicting muscle-invasive bladder cancer: A diagnostic meta-analysis. International journal of urology : official journal of the Japanese Urological Association 29 (3) (2021)
Koichiro Kimura, Soichiro Yoshida, Junichi Tsuchiya, Ichiro Yamada, Hajime Tanaka, Minato Yokoyama, Yoh Matsuoka, Ryoichi Yoshimura, Ukihide Tateishi, Yasuhisa Fujii
Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer. European radiology 32 (1) (2021)
Soichiro Yoshida, Yasuhisa Fujii
Editorial Comment to Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer. IJU case reports 4 (2) (2020)